ReviewFrontiers in bioengineering and biotechnology2022

Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis-An updated review.

Prakash Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.